Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of ß-blockers, nitrates and calcium antagonists


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Nicorandil significantly reducted the incidence of major coronary events in patients with stable angina in a long-term trial, although there are few reports on its short-term efficacy in the treatment and prevention of angina symptoms. We performed a meta-analysis of the short-term efficacy of nicorandil compared with antianginal drugs for stable angina.

Full Text

Restricted Access

About the authors

Yu. Hanai

Toho University, Omori Medical Center

Email: yuuki.hanai@med.toho-u.ac.jp
Tokyo, Japan

M. Mita

Meiji Pharmaceutical University

Email: yuuki.hanai@med.toho-u.ac.jp
Tokyo, Japan

Sh. Hishinuma

Meiji Pharmaceutical University

Email: yuuki.hanai@med.toho-u.ac.jp
Tokyo, Japan

M. Shoji

Meiji Pharmaceutical University

Email: yuuki.hanai@med.toho-u.ac.jp
Tokyo, Japan

References

  1. Ministry of Health, Labour and Welfare: http://www.mhlw.go.jp/toukei/saikin/ hw/jinkou/kakutei07/index.html. ffled 20 February, 2010.
  2. Goldschmidt M., Landzberg B., Frishman W. J. Clin. Pharmacol. - 1996; 36: 559-72. https://doi.org/10.1002/j.1552-4604.1996.tb04219.x
  3. IONA Study Group. Lancet. - 2002; 359 (9314): 1269-75. DOI: 10.1016/ S0140-6736(02)08265-X
  4. Heidenreich P., McDonaldK. M., Hastie T. et al. JAMA. - 1999; 281: 1927-36.
  5. Sculpher M., Petticrew M., Kelland J. et al. Health Technol. Assess. - 1998; 2 (10): 1-176.
  6. The American College of Cardiology Foundation and the American Heart Association, Inc., http://www.americanheart.org/downloadable/ heart/1044991838085StableAngina NewFigs.pdf. ffled 5 September, 2010.
  7. Fraker T. Jr., Fihn S., Gibbons R. et al. Circulation. - 2007; 116: 2762-72. doi: 10.1161/CIRCULATIONAHA.107.187930
  8. Fox K., Garcia M., Ardissino D. et al. Eur. Heart J. - 2006; 27: 1341-81. doi: 10.1093/eurheartj/ehl001
  9. Management of Stable Angina: A National Clinical Guideline. Ed. By Scottish Intercollegiate Guidelines Network, SIGN / Edinburgh, 2007.
  10. Murao S., Kimura E. Jpn. J. Clin. Pharmacol. Ther. - 1982; 13: 311-26.
  11. Yamagami T., Akagami H., Maeda Y. et al. Current Therapy. - 1986; 4: 113-29.
  12. Hughes L., Rose E., Lahiri A. et al. Am. J. Cardiol. - 1990; 66: 679-82.
  13. Meeter K., Kelder J., Tijssen J. et al. J. Cardiovasc. Pharmacol. - 1992; 20 (Suppl. 3): 59-66.
  14. DiSomma S., Liguori V., Petitto M. et al. Cardiovasc. Drugs Ther. - 1993; 7: 119-23.
  15. Tomita F., Kohya T., Kaji T. et al. Therapeutic Reserch. - 1994; 15: 1437-9.
  16. Mimura G., Irei M., Kinjo K. et al. Jpn. Pharmacol. Ther. - 1985; 13: 4203-16.
  17. Lai C., Onnis E., Solinas R. et al. Cardiologia. - 1991; 36: 703-11.
  18. Doring G. J. Cardiovasc. Pharmacol. - 1992; 20 (Suppl. 3): 74-81.
  19. Falcone C., Auguadro C., Chioffi M. et al. Eur. Heart. J. - 1993; 14 (Suppl): 376.
  20. Udaykumar P., Adhikari P., Periera P. JIACM. - 2003; 4: 205-9.
  21. Zhu W., Shan Y., Guo J. et al. Circ. J. - 2007; 71: 826-33. https://doi. org/10.1253/circj.71.826
  22. Yamada K., Takezawa H., Toyama S. et al. Jpn. J. Clin. Exp. Med. - 1982; 59: 2079-89.
  23. Kurogane H., Minamiji K., Hamamori Y. et al. Jpn. J. Med. Pharm. Sci. -1987; 17: 721-30.
  24. Nakamura Y., Kato S., Handa S. et al. Therapeutic Reserch. - 1989; 10: 1331-7.
  25. Sasaki J., Saeki Y., Kawasaki K. et al. Cardiovasc. Drugs Ther. - 1992; 6: 471-4.
  26. Ulvenstam G., Diderholm E., Frithz G. et al. J. Cardiovasc. Pharmacol. -1992; 20 (Suppl. 3): 67-73.
  27. Guermonprez J., Blin P., Peterlongo F. Eur. Heart J. - 1993; 14 (Suppl. B): 30-4.
  28. Ohyama Y., Nihei T., Miyata T. et al. Therapeutic Reserch. - 1993; 14: 857-61.
  29. The SWAN Study Group. J. Clin. Basic Cardiol. - 1999; 2: 213-7.
  30. Jadad A., Moore R., Carroll D. et al. Control. Clin. Trials. - 1996; 17: 1-12.
  31. Frydman A. J. Cardiovasc. Pharmacol. - 1992; 20 (Suppl. 3): 34-44.
  32. Rajaratnam R., Brieger D., Hawkins R. et al. Am. J. Cardiol. - 1999; 83: 1120-4. doi: 10.1016/S0002-9149(99)00025-9
  33. Frampton J., Buckley M., Fitton A. Drugs. - 1992; 44: 625-55.
  34. Uchida Y. Jpn. J. Med. Pharm. Sci. - 1978; 8: 1705-16.
  35. Nogi S., Nishiyama T., Akabane F. et al. PharmaMedica. - 2003; 21: 163-8.
  36. Kato T., Noda K. Jpn. J. Electrocardiol. - 2006; 26: 47-55.
  37. Pepine C., Cohn P., Deedwania P. et al. Circulation. - 1994; 90: 762-8.
  38. Poole-Wilson P., Lubsen J., Kirwan B. et al. Lancet. - 2004; 364: 849-57.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies